Evidence map›Paper›PMID 41252096›Full record

ReviewMolecular and cellular biochemistry2026

How cells die determines the consequences of tissue repair: roles of programmed cell death in lung injury on the progression of pulmonary fibrosis.

Linying Zhou, Xi Zhu, Ershi Hua, Liqin Xu, Jian Feng

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Linying ZhouDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital and Medical School of Nantong University, Nantong, 226001, Jiangsu, China.
Xi ZhuDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital and Medical School of Nantong University, Nantong, 226001, Jiangsu, China.
Ershi HuaDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital and Medical School of Nantong University, Nantong, 226001, Jiangsu, China.
Liqin XuDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital and Medical School of Nantong University, Nantong, 226001, Jiangsu, China.
Jian FengDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital and Medical School of Nantong University, Nantong, 226001, Jiangsu, China. jfeng68@126.com.ORCID http://orcid.org/0000-0003-4248-4237

Funding

Jiangsu Provincial Research Hospital YJXYY202204-XKA02
6 · The paper itself

Abstract

Pulmonary fibrosis (PF) is a pathological change in the development of end-stage lung disease, referring to an irreversible lesion in which lung tissue undergoes an abnormal repair response during injury repair, resulting in the replacement of normal alveolar structure by fibrous scarring. The main mechanisms of pulmonary fibrosis progression are activation of epithelial cell and macrophage repair after oxidative stress, fibroblast proliferation leading to extracellular matrix deposition in the lung, and a repair process involving multiple modes of death and molecular mechanisms that cross-talk in macrophages and alveolar epithelial cells, accelerating extracellular matrix deposition. Cell death is controlled by programmed cell death (PCD), which mainly includes apoptosis, necrotic apoptosis, pyroptosis, ferroptosis and autophagy. There is increasing evidence that PCD plays an important role in the pathogenesis of pulmonary fibrosis progression. In this review, we discuss recent advances in the role of PCD in lung injury-accelerated fibrosis, show how the mode of death of alveolar epithelial cells, macrophages, and fibroblasts promotes or inhibits the progression of lung injury, and explore associations between different types of PCD, with the aim of exploring the molecular mechanisms underlying the progression of recurrent lung injury and searching for new therapeutic targets.

Indexed as

ApoptosisLung InjuryPulmonary FibrosisAnimalsDisease ProgressionFibroblastsHumansLung injuryProgrammed cell deathPulmonary fibrosis

Identifiers

PMID41252096

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.